On meta-analytic assessment of surrogate outcomes
From MaRDI portal
Publication:4521868
DOI10.1093/biostatistics/1.3.231zbMath1072.62657OpenAlexW2108464948WikidataQ47671594 ScholiaQ47671594MaRDI QIDQ4521868
Mitchell H. Gail, Hans C. van Houwelingen, Ruth M. Pfeiffer, Raymond J. Carroll
Publication date: 2000
Published in: Biostatistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biostatistics/1.3.231
Related Items
Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling, Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time, Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints, On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints, Multivariate meta‐analysis with an increasing number of parameters, Simplified modeling strategies for surrogate validation with multivariate failure-time data, The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials, Statistical evaluation of surrogate endpoints with examples from cancer clinical trials, Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials, The Evaluation of Multiple Surrogate Endpoints, Principal Stratification in Causal Inference, Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS, On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm, Surrogate Measures and Consistent Surrogates